Vanda Pharmaceuticals VNDA Stock Down 072 Support Test at 593 20260518 AI Dominance Redefines the 2026 CNBC Disruptor 50 Valuation Triples as Growth Takes Center Stage Trumps Iran Threat Berkshires Airline Bet Lululemon Proxy Battle Market Movers May 2026 Brook Renew BEP Posts Weak Q1 2026 Misses on Both Top and Bottom Lines AI Financing Drives Surge in US Convertible Bond Issuance Precigen PGEN Posts Q1 2026 Earnings Beat Heres What Drove It Corgis Valuation Soars to 26 Billion With Latest 106M Raise Doubling in Three Weeks RGR Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales and Item Volume BIRK Q1 2026 Earnings EPS Misses Estimates Amid Operational Progress Stock Rises Modestly NPK Q3 2023 Earnings EPS of 099 Reported Amid Limited Financial Disclosure BCSF Q1 2026 Earnings EPS Misses Expectations by 273 as Stock Slightly Declines CHH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment MRBK Q1 2026 Earnings EPS Misses Expectations by Nearly 20 Shares Edge Higher Tillys Inc TLYS Q1 2026 Earnings Stunning EPS Beat Drives Shares Higher Despite Revenue Uncertainty Aeluma Inc ALMU Q1 2026 Earnings Narrow EPS Beat Fails to Lift Investor Sentiment